{"date":"2026-04-29","count":42,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6496-2026-04-29-1933-1rsej86","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"19:33:30","subject":"公告本公司115年度第一季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-04-29 19:33，「公告本公司115年度第一季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-04-29-1823-17q69gt","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-04-29","time":"18:23:51","subject":"公告本公司股票初次創新板上市前現金增資發行新股相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-04-29 18:23，「公告本公司股票初次創新板上市前現金增資發行新股相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-04-29-1823-1uaf23b","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-04-29","time":"18:23:19","subject":"公告本公司股務代理機構名稱、辦事處所及聯絡電話","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-04-29 18:23，「公告本公司股務代理機構名稱、辦事處所及聯絡電話」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-04-29-1801-70zw8o","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"18:01:05","subject":"公告本公司115年第一季財務報告董事會預計召開日期為115年5月7日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-04-29 18:01，「公告本公司115年第一季財務報告董事會預計召開日期為115年5月7日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-04-29-1756-l066sj","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"17:56:27","subject":"公告115年第1季財務報告董事會預計召開日期為115年5月7日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-04-29 17:56，「公告115年第1季財務報告董事會預計召開日期為115年5月7日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-04-29-1748-lg8jlk","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"17:48:45","subject":"本公司115年第一季財務報告董事會預計召開日期為115年05月07日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-04-29 17:48，「本公司115年第一季財務報告董事會預計召開日期為115年05月07日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-04-29-1742-6zon6z","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"17:42:24","subject":"本公司向菲律賓食品藥物管理局 (Philippine FDA) 提交恩穩健腸病毒71型疫苗新藥審查 (NDA)","clause":"第10款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-04-29 17:42，「本公司向菲律賓食品藥物管理局 (Philippine FDA) 提交恩穩健腸病毒71型疫苗新藥審查 (NDA)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-04-29-1740-1sayam8","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"17:40:16","subject":"公告本公司115年第一季合併財務報告董事會預計召開日期為115年5月11日","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-04-29 17:40，「公告本公司115年第一季合併財務報告董事會預計召開日期為115年5月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-04-29-1736-ag0ktz","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"17:36:03","subject":"本公司受邀參加永豐金證券舉辦之線上法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-04-29 17:36，「本公司受邀參加永豐金證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-04-29-1735-y8ephz","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-04-29","time":"17:35:35","subject":"公告本公司115年第一季財務合併報告董事會預計召開日期為115年5月7日。","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-04-29 17:35，「公告本公司115年第一季財務合併報告董事會預計召開日期為115年5月7日。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-04-29-1730-134g2u8","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"17:30:16","subject":"公告本公司115年第一季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-04-29 17:30，「公告本公司115年第一季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-04-29-1728-1v20vp9","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-04-29","time":"17:28:14","subject":"公告本公司董事會決議辦理現金增資發行新股案","clause":"第9款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-04-29 17:28，「公告本公司董事會決議辦理現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2026-04-29-1720-1md7lum","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-04-29","time":"17:20:41","subject":"公告本公司「瑞特安活2連續葡萄糖監測系統(RIGHTEST iFree2 CGM)」取得衛生福利部食藥署(TFDA)核發第二等級醫療器材許可證核准通知","clause":"第51款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-04-29 17:20，「公告本公司「瑞特安活2連續葡萄糖監測系統(RIGHTEST iFree2 CGM)」取得衛生福利部食藥署(TFDA)核發」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-04-29-1719-7zo3i1","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"17:19:10","subject":"公告本公司董事會通過資金貸與子公司案。","clause":"第23款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-04-29 17:19，「公告本公司董事會通過資金貸與子公司案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-04-29-1716-16febev","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"17:16:32","subject":"公告本公司董事會通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-04-29 17:16，「公告本公司董事會通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-04-29-1703-1tnj5a6","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-04-29","time":"17:03:15","subject":"本公司會計主管、財務主管、代理發言人異動","clause":"第11款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-04-29 17:03，「本公司會計主管、財務主管、代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-04-29-1659-6rqyk5","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"16:59:01","subject":"公告本公司取得有價證券","clause":"第20款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-04-29 16:59，「公告本公司取得有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-04-29-1658-142x1c5","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-04-29","time":"16:58:11","subject":"公告本公司115年第一季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-04-29 16:58，「公告本公司115年第一季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2026-04-29-1656-ednpy8","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"16:56:01","subject":"公告本公司董事會通過115年第1季個別財務報告","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2026-04-29 16:56，「公告本公司董事會通過115年第1季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2026-04-29-1648-vl81e7","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"16:48:16","subject":"公告本公司115年第1季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：精華（1565），2026-04-29 16:48，「公告本公司115年第1季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-04-29-1643-134g2u8","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"16:43:13","subject":"公告本公司115年第一季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-04-29 16:43，「公告本公司115年第一季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-04-29-1632-u8aepm","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"16:32:15","subject":"公告本公司國內第八次無擔保轉換公司債收足應募價款","clause":"第53款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-04-29 16:32，「公告本公司國內第八次無擔保轉換公司債收足應募價款」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-04-29-1609-f93hal","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-04-29","time":"16:09:39","subject":"公告本公司董事會通過115年第一季個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-04-29 16:09，「公告本公司董事會通過115年第一季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2026-04-29-1551-t3bsot","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-04-29","time":"15:51:49","subject":"公告本公司財務主管、會計主管、公司治理主管及代理發言人異動","clause":"第11款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-04-29 15:51，「公告本公司財務主管、會計主管、公司治理主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-04-29-1551-11gbyng","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"15:51:38","subject":"公告本公司董事會決議召開115年股東常會事宜(新增報告事項)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-04-29 15:51，「公告本公司董事會決議召開115年股東常會事宜(新增報告事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-04-29-1551-i0lc2","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"15:51:20","subject":"公告本公司訂定除權基準日等相關事宜","clause":"第14款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-04-29 15:51，「公告本公司訂定除權基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2026-04-29-1549-1b6odvk","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2026-04-29","time":"15:49:50","subject":"本公司董事會決議召開115年股東常會(新增議案)","clause":"第32款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2026-04-29 15:49，「本公司董事會決議召開115年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-04-29-1548-1d5h248","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"15:48:53","subject":"公告本公司115年第一季財務報告董事會召開日期為115年5月7日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-04-29 15:48，「公告本公司115年第一季財務報告董事會召開日期為115年5月7日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-04-29-1539-441vkr","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-04-29","time":"15:39:30","subject":"公告本公司股票初次上市前現金增資發行新股承銷價格","clause":"第44款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-04-29 15:39，「公告本公司股票初次上市前現金增資發行新股承銷價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-04-29-1529-2d1re4","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-04-29","time":"15:29:53","subject":"代重要子公司振泰檢驗科技股份有限公司公告董事會決議不發放股利","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-04-29 15:29，「代重要子公司振泰檢驗科技股份有限公司公告董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-04-29-1527-12xzpgn","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-04-29","time":"15:27:53","subject":"代重要子公司台美檢驗科技股份有限公司公告董事會決議發放現金股利","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-04-29 15:27，「代重要子公司台美檢驗科技股份有限公司公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2026-04-29-1526-l066sj","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"15:26:48","subject":"公告115年第1季財務報告董事會預計召開日期為115年5月7日","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2026-04-29 15:26，「公告115年第1季財務報告董事會預計召開日期為115年5月7日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-04-29-1524-yi255p","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"15:24:49","subject":"本公司將於115年5月14日召開上櫃前業績發表會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-04-29 15:24，「本公司將於115年5月14日召開上櫃前業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-04-29-1520-usi1ve","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-04-29","time":"15:20:24","subject":"本公司股票即將終止興櫃交易並轉至臺灣證券交易所上市交易","clause":"第28款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-04-29 15:20，「本公司股票即將終止興櫃交易並轉至臺灣證券交易所上市交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-04-29-1510-1banbn1","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-04-29","time":"15:10:30","subject":"本公司董事會決議辦理現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-04-29 15:10，「本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-04-29-1440-dbyetg","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"14:40:56","subject":"公告本公司民國115年第一季財務報告董事會預計召開日期為民國115年5月7日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-04-29 14:40，「公告本公司民國115年第一季財務報告董事會預計召開日期為民國115年5月7日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2026-04-29-1430-ifcpm2","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"14:30:13","subject":"公告本公司115年第1季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2026-04-29 14:30，「公告本公司115年第1季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-04-29-1427-ed4cxb","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-04-29","time":"14:27:09","subject":"修正115年03月26日和115年03月27日重大訊息第12項第1點內容","clause":"第44款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-04-29 14:27，「修正115年03月26日和115年03月27日重大訊息第12項第1點內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2026-04-29-1410-134g2u8","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"14:10:27","subject":"公告本公司115年第一季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：德英（4911），2026-04-29 14:10，「公告本公司115年第一季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-04-29-1126-qp6vc","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"11:26:30","subject":"公告本公司115年3月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第53款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-04-29 11:26，「公告本公司115年3月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-04-29-1042-19l37c2","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-29","time":"10:42:01","subject":"公告本公司115年度第一季財務報告董事會預計召開日期為115年5月7日","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-04-29 10:42，「公告本公司115年度第一季財務報告董事會預計召開日期為115年5月7日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-04-29-0959-1nrcoya","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-04-29","time":"09:59:52","subject":"公告115年第一季財務報告董事會預計召開日期為115年5月7日","clause":"第31款","fact_date":"2026-04-29","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-04-29 09:59，「公告115年第一季財務報告董事會預計召開日期為115年5月7日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}